Top Banner
Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center
82

Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Dec 27, 2015

Download

Documents

Harry McKenzie
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Surgical Treatment of PA with VSD without/with MAPCA

Jeong-Jun Park

University of Ulsan, Asan Medical Center

Page 2: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Pulmonary Atresia with VSD without/with MAPCA

1. Extreme subgroup of Tetralogy of Fallot Extreme subgroup of Tetralogy of Fallot 2. Major clinical problems in the arteries that2. Major clinical problems in the arteries that supply the pulmonary circulationsupply the pulmonary circulation

3. Variable clinical presentations & different 3. Variable clinical presentations & different surgical strategies to that in TOF/PSsurgical strategies to that in TOF/PS

Page 3: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Morphology of PA with VSD

The general morphology of the heart in TOF/PA - Similar to that in simple TOF,

- The differentiating features are :

1. No luminal continuity between RV & PA 2. Pulmonary arterial anomalies 3. Aortopulmonary collaterals

Page 4: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Natural History

Variable depending on the pulmonary blood flow

- At birth, ductus dependent in case of true PAs

- After ductal closure, dependent on the collaterals

1) Excessive pulmonary blood flow : CHF, PVOD 2) Moderate collateral stenosis : Balanced pulmonary blood flow 3) Severe collateral stenosis : hypoxia

Page 5: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Patterns of Pulmonary Arteries

Page 6: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Morphology of Pulmonary Artery

1. Confluence of the pulmonary artery

2. Stenosis of the pulmonary artery

3. Distribution of the pulmonary artery

4. Size of the pulmonary artery

5. Abnormal hilar branching

Page 7: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Alternative Sources of PBF

1. MAPCAs 2. Paramediastinal collateral arteries 3. Bronchial collateral arteries 4. Intercostal collateral arteries 5. Collaterals from coronary arteries 6. Iatrogenically aggravated collaterals

Page 8: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Origin of MAPCA

MAPCAs - Variable in size, number, course, origin, arborization &

histologic makeup - Usually large & discrete arteries from 1 to 7 in number

1. Majority from descending thoracic aorta 2. Some cases, from a common aortic trunk3. Finally, from branches of aorta

Page 9: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Influence of MAPCA

1. Chronic shunt & LV volume overload . Decrease LV function . Aortic annular dilatation . Aortic insufficiency

2. Segmental loss of lung parenchyme . In case of collateral stenosis --hypoxia . In unobstructed cases – CHF, PVOD

Page 10: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Histologic Characteristics of MAPCAs

1. Extrapulmonary: muscular artery with well developed muscular media & adventitia

2. Intrapulmonary:medial muscle is gradually replaced by a thin elastic lamina resembling true Pas

3. Unobstructed MAPCAs: PVOD4. Muscular segments of collaterals:

prone to the development of severe stenoses, often progressive

Page 11: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Characteristic Features of MAPCAs

1. Variable in size, number, course, origin, arborization and histologic makeup

2. Various degree of PA hypoplasia , or even absence of the central PAs

3. MAPCAs connect with branches of central PAs, or constitute the only blood supply

4. Congenital or acquired discrete stenosis along the course of MAPCAs

5. PHT and progressive PVOD

Page 12: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.
Page 13: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

* Confluent PA

Page 14: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Unobstructed MAPCA

Page 15: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Long stenotic segment

Page 16: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

MAPCA = Dilated Bronchial Arteries - RCH, 2006 - All MAPCAs : anatomy similar to bronchial arteries

- BAs: limited growth potential and vasoreactivity might preclude long-term beneficial effects of unifocalization

Bronchopulmonary shunts

Page 17: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Definitive Repair of PA with VSD

Ultimate goal : Completely separated pulmonary & systemic circulati

on

1. Closure of ventricular septal defect 2. Establish continuity between RV & PA 3. Occlusion of redundant collaterals & shunts / Unif

ocalization

Page 18: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Preparation for Definitive Repair

1. Maximize the pulmonary artery

: The size & distribution

2. Maintain the adequate PBF

3. Avoid the excessive PBF

Page 19: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Suggested Surgical Strategy for

PA with VSD, MAPCA

1. Unifocalization - Staged vs one-stage - Thoracotomy vs sternotomy 2. Establishment of native PA growth - With vs without unifocalization 3. One-stage complete repair 4. Repair without unifocalization

Page 20: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Early Palliative Procedures

Goals 1) Create a balanced PBF 2) Incorporation & growth of PAs

- Ligation- Embolization- Creating stenosis

- Systemic-pulmonary shunt - RV-PA connection : conduit or outflow patch - Unifocalization

Excessive blood flow Inadequate blood flow

Page 21: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Ideal Unifocalization Procedure

1. Incorporation of all the nonredundant collaterals & true Pas

healthy microvasculature of lung2. Use conduit that is growing, large, & minimizi

ng the risk of thrombosis3. Easily accessible from the mediastinum

at the time of definitive repair

Page 22: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Timing of Unifocalization

1. At any age, when collaterals are large to allow tec

hnical ease without risk of thrombosis

2. Variable depending on collateral size, usually old

er than 2~3 months

3. Staged procedures may be required for the bila

teral aortopulmonary collaterals

Page 23: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Techniques of Unifocalization

1. Procedures for collaterals 1) Ligation

2) Patch enlargement3) Direct anastomosis

2. Interposition grafts1) Synthetic graft2) Homograft3) Xenograft 4) Autologous tissue: pericardium, azygos v.

Page 24: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

• Ligation

• Angioplasty

• Anastomosis

Unifocalization Procedures

Page 25: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

• Interposition

• Additional PA creation

• Central PA creation

Unifocalization Procedures

Page 26: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

End-to side Side -to side

- Offbypass during dissection - Maximal use of native tissue - Avoid circumferential use of non-viable conduits for growth potential

Surgical technique of unifocalization

Page 27: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Aortic button : several MAPCAs from the same location

Surgical technique of unifocalization

Page 28: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Surgical technique of unifocalization

Page 29: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

RV-PA Conduit

Page 30: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Advantages of RV - PA Connection

1. Reduction of LV volume overload

2. Pulsatile blood flow to enhance PA growth

3. Facilitating the catheter access for the later evaluation & intervention

** CIx d/t

1) aneurysm and pseudoaneurysm

2) pulmonary flow and pressure is completely uncontrolled

Page 31: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Melbourne Shunt

Central end-to-side Aortopulmonary shunt Diminutive central pulmonary arteries

Page 32: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Modified Central Shunt

Page 33: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Criteria for VSD closure: 2 Dimensional Anatomic Data

- Central PA area 50% of predicted normal

- by Puga, 1989

- Predicted pRV/pLV 0.7, No MAPCAs remain

More than 2/3 lung segments are centralized

- by Iyer and Mee, 1991

- Nakata Index > 150mm2/M2 BSA -by Metras, 2001

- TNPAI 200 mm2/m2 - by Hanley, 1997

- 15 out of 20 bronchopulmonary segments(1 & 1/2 lungs) are connected to confluent pulmonary artery

- by Baker, 2002

Page 34: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Functional Intraoperative Pulmoanry Blood Flow Study

* Post-repair RVSP: most reliable predictor of favorable outcome

* Data of functionality of the entire pul. vasculature

Hanley - m PAP < 25mmHg at a full flow(2.5L/min/m2) predicts RV/LV pressure ratio < 0.5

Toronto, 2009- Close the VSD for a mPAP of <30mmHg- Predict postop. Physiology better than standard anatomic measures

Page 35: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Functional Intraoperative PBF Study

Page 36: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

- RCH, 2009- Unifocalization brings no long-term benefits . Unifocalization: sufficient to allow a safe repair but, failed to achieve adequate growth . Dilated BAs: limited growth potential & unstable Growth of the native PA rather than recruitment of MAPCAs- Multi-stage approach . 4~6wks: Modified central shunt . 4~6months: RV-PA conduit . 3rd : complete repair or 2nd conduit- 18 pts enrolled in this protocol (No Unifocalization) . 7 : complete repair, RVP 59% of systemic . 8 : awaiting repair . 4 MAPCAs in 17 pts: ligated

Repair without Unifocalization

Page 37: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Advantages of One-stage Complete Repair

1. Eliminate the need for multiple operations

2. Eliminate the use of prosthetic materials

3. Establish the normal physiology early in life 1) Growth of respiratory & PA system 2) Avoid cyanosis & volume overload 3) Prevent the PVOD

Page 38: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Disadvantages of Multistage Approach

1. The final repair is achieved on an old age

2. Mediastinum & hilar regions are significantly

scarred, increasing surgical risks

3. Prolonged cyanosis & previous operation cause

secondary collaterals, risks of bleeding

4. The risk of drop-off before the final repair

Page 39: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Disadvantages of Earlier Repair

1. Increased pulmonary morbidity

1) Contusion & congestion

2) Bronchospasm

3) Phrenic nerve injury

2. Magnitude of operation

3. Technically more demanding

4. Unknown ideal age

Page 40: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Conclusion

- MAPCAs: Wide spectrum of pul. vascualr morphology and physiology, Ranging 1) from pts on the favorable end : true PAs with collaterals simply contributing systemic flow into the pul. vasculature 2) to pts on the unfavorable end : with completely absent native PAs and all of the pulmonary blood supply from collaterals

Management: complex and must be individualized according to their anatomy and clinical situations

Page 41: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.
Page 42: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.
Page 43: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.
Page 44: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.
Page 45: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.
Page 46: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.
Page 47: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.
Page 48: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Predictors of Successful Definitive Repair

1. McGoon Ratio > 12. Nakata Index > 150mm2/M2 BSA(Metras, 2001)

추가하자3. TNPAI > 200mm2/M2 BSA4. Ideal Age : Not known , but usually more than 2-3years old for conduit repair5. 15 out of 20 bronchopulmonary segments(1 & 1/2 lungs)

are connected to confluent pulmonary artery: Baker EJ. 2002

Page 49: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Selection for Final Repair

1. Central combined Rt. & Lt. PA area : At least 50~75% of predicted normal

2. Distribution of unobstructed confluent PAs : Equivalent to at least one whole lung

3. Presence of a predominant Lt. to Rt. shunt without restrictive RV-PA connection

Page 50: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Representative Data

Approach Age(range)

VSD closure

Mortality(early)

Mee RBB(’91)

Multiple 2.6mo(1d ~ 39yr)

52%(30/55

)

10%

Hanley FL(’95)

Anterior 2yr(2mo ~ 37yr)

90%(9/10) -

Hanley FL(’97)

Anterior 4mo(10d ~ 11mo)

63%(17/27

)

7%

Hanley FL(’98)

Anterior 7.3mo(14d ~ 37yr)

64%(46/72

)

11%

Lofland GK(’00)

Anterior 3mo(5d ~

5.5mo)

91%(10/11)

9.1%

Cherian KM(’02)

Anterior 36mo(6mo ~ 23yr)

51%(26/51

)

16%

Page 51: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Midline One-stage Unifocalization

Page 52: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Staged Unifocalization & RV-PA Connection

Page 53: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

One-stage Unifocalization & RV-PA Connection

Page 54: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

RVOT Reconstruction with Valved Conduit

Page 55: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

RVOT Reconstruction with Outflow Patch

Page 56: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

RVOT Reconstruction with PA Reimplantation

Page 57: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

RVOT Reconstruction with LA Appendage

Page 58: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

RVOT Reconstruction with PA Flap

Page 59: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

RV-PA Connection & Unifocalization

Page 60: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

RV-PA Connection with Unifocalization

Page 61: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Midline One-stage Repair

Page 62: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Midline One-stage Repair

Page 63: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Staged Unifocalization Staged Unifocalization

• M / 20 Mo, 10.6 kg Postop. 7 Mo

Page 64: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

One-stage Unifocalization

One-stage Unifocalization

• M / 46 Mo, 13 kg Post-op. 8 Mo

Page 65: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

RV-PA Connection RV-PA Connection

• F / 3 Mo, 4.6 kg Post-op. 3 Mo

Page 66: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

RV-PA Connection with Unifocalization

RV-PA Connection with Unifocalization

• F / 15 Mo, 7.5kg Post-op. 11 Mo

Page 67: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

One-stage Total Correction

One-stage Total Correction

• M / 7 Mo, 6.4kg Post-op. 1 Mo

Page 68: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Surgical Results of PA with VSD,MAPCAs

Yang Gie Ryu, Jeong-Jun Park,Tae Jin Yoon, Dong Man Seo

Dept. of Thoracic and Cardiovascular SurgeryAMC, University of Ulsan

- Anterior approach - Anterior approach --

Page 69: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Representative Data

Approach Age(range)

VSD closure

Mortality(early)

Mee RBB(’91)

Multiple 2.6mo(1d ~ 39yr)

52%(30/55

)

10%

Hanley FL(’95)

Anterior 2yr(2mo ~ 37yr)

90%(9/10) -

Hanley FL(’97)

Anterior 4mo(10d ~ 11mo)

63%(17/27

)

7%

Hanley FL(’98)

Anterior 7.3mo(14d ~ 37yr)

64%(46/72

)

11%

Lofland GK(’00)

Anterior 3mo(5d ~

5.5mo)

91%(10/11)

9.1%

Cherian KM(’02)

Anterior 36mo(6mo ~ 23yr)

51%(26/51

)

16%

Page 70: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Criteria for VSD closure

- Central PA area 50% of predicted normal (by Puga, 1989)

- Predicted pRV/pLV 0.7 No MAPCAs remain More than 2/3 lung segments are centralized (by Iyer and Mee, 1991)

- TNPAI 200 mm2/m2 (by Hanley, 1997)

- ? Unprotected large MAPCA

Page 71: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Patient Profile

Period Jan. 1997 ~ Jul.

2002

Number 25 (M : F = 12 : 13)

Age(mo), median 8 (3 ~ 190)

Weight(kg), median 6.8 (2.9 ~ 62)

Follow-up(mo), median 16 (3 ~ 150)

Page 72: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

PA,VSD,MAPCAs(n=25)

PA,VSD,MAPCAs(n=25)

Gr Ia One stage total

(n=11)

Gr Ib Staged total

(n=8)Group II (n=6)

VSD closed (n=19,76%)

VSD open (n=6,24%

)

Page 73: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Group Ia (VSD closed)

Group Ib(VSD closed)

Group II( VSD open )

No. of

pts(%)11(44) 8(32) 6(24)

Age(mo) Median Range

83 ~ 11

10.54 ~ 190

10.55 ~ 58

Weight(kg) Median Range

6.72.9 ~ 8.1

8.055 ~ 62

7.95.1 ~ 15.8

Demographic Data

Page 74: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

MAPCAs & True PAs

Group Ia(VSD closed)

Group Ib(VSD closed)

Group II(VSD

open)

No. of MAPCAs Mean Range

3.6 1.21 ~ 5

3.3 1.31 ~ 5

3.6 0.53 ~ 4

True PAs Present Absent

74

71

60

Page 75: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Operation

Group Ia(VSD closed)

Group Ib(VSD closed)

Group II(VSD open)

Total

Surgical approach Median sternotomy Sternotomy + thoracotomy

74

62

42

178

RV-PA conduit Homograft Pericardial roll Transannular patch

821

512

311

1644

Page 76: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Detail of Group Ia (n=11)

Pt Confluency of PA Neo-McGoon ratio No. of MAPCAs Age

1 - < 2.0 5 4m

2 + Hypoplastic > 2.0 4 8m

3 + Hypoplastic > 2.0 4 6m

4 - > 2.0 4 12m

5 + Good > 2.0 3 6m

6 + Hypoplastic < 2.0 5 10m

7 + Good > 2.0 5 8m

8 + Good > 2.0 1 4m

9 + Good < 2.0 3 4m

10 - > 2.0 3 8m

11 - > 2.0 3 9m

# Neo-McGoon ratio = (True PA + each MAPCA) / descending aorta

Page 77: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Detail of Group Ib (n=8)Pt Confluency of PA Neo-McGoon r

atioNo. of MAPCA

1st Op(Age)

2nd Op(Age)

1 + Hypoplastic < 1.5 3 RV-PA conduit 11m

Total 16m

2 + Hypoplastic < 2.0 3 Lt.unif 8m

Rt.unif 22m

3 - > 2.0 5 Rt.unif 13m

Total 6y 6m

4 + Hypoplastic > 2.0 4 RVOT relieve 5m

Total 10m

5 + Hypoplastic > 2.0 4 RVOT relieve,unif 8m

Total 18m

6 + Hypoplastic AP window

> 2.0 1 RV-PA conduit,unif 9m

Total 10m

7 + Hypoplastic > 2.0 3 RV-PA conduit,unif 16m

Total 3y 1m

8 + > 2.0 1 RV-PA conduit,unif 15y 10m

Total 24y 1m

Page 78: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Detail of Group II (n=6)

Pt Confluency of PA Neo-McGoon ratio

No. of MAPCAs

Op name(Age) Outcome

1 + Hypoplastic

< 2.0 3 Bilat.unif,Central shunt,RV-PA conduit

Cath F/U

2 + Hypoplastic < 2.0 4 RV-PA conduit 6m

Poor growth of PA->death

3 + Hypoplastic

> 2.0 4 RV-PA continuity 10m

Waiting

4 + Hypoplastic < 1.0 4 RV-PA conduit,unif 3y 2m

Waiting

5 - < 1.5 3 Bilat.unif 6m

Observ.

6 + Hypoplastic > 2.0 1 RMBT,cetral shuntRV-PA conduit(9m)

Death

Page 79: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Gr Age Anatomy Cause of death

Ia 4m PA,VSD, 5 MAPCA Respiratory failureBronchial stenosis

Ia 6m PA, VSD, 4 MAPCA Pulmonary Hemorrhage *

Ia 6m PA,VSD, 4 MAPCA Pulm. Hypertensive crisis *

Ia 12m PA,VSD, 4 MAPCA Bronchus compression

II 6m PA,VSD, 4 MAPCA Poor growth of PAs

II 4y 11m

PA, VSD, 1 MAPCA PVOD *

Cases of Mortality (n=6)

* Pulmonary hypertension related

Page 80: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Total correction 76% (19/25)

One stage total correction 44% (11/25)

Early mortality 16% (4/25)

Late mortality 9% (2/21)

Results

Page 81: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Conclusion

Anterior approach 는 수술의 완성도를 높일 수 있는 술식이다 (>80%).

Too small or unprotected large MAPCA를

recruit 하기 위해서는 적절한 시기에 수술이 필요하다 .

PVR 이 높을 것으로 의심되는 경우는 staged op. 이 reasonable 하겠다 .

Page 82: Surgical Treatment of PA with VSD without/with MAPCA Jeong-Jun Park University of Ulsan, Asan Medical Center.

Conclusion

Just now we are ready

to manage this group of patients properly

in technique and hemodynamic understanding.